TitanIvy International LP

Forward-looking vision with deep innovation experience

Understand value creation and strategic opportunities

Deep resources, domain experience and expertise

TitanIvy International is a global crossover / pre-IPO fund managed by a team that has collectively achieved exits worth over $20 Billion+.
 

Extensive Public and Private Markets Experience & Strong Operational Expertise

Extensive expertise in steering the operations of publicly traded companies & current and past engagements have involved pivotal roles as Chairman, CEO, and Board Members in notable organizations, including The Bancorp, ApolloMed, Clinigence Holdings, and Cardio Diagnostics.

  • $5 Billion+ in de-SPACs

    Have been involved with 10 SPACs, raising a total of $2 billion+ in capital, successful closure and announcement of 7 de-SPAC transactions, totaling a transaction value of $5 billion+

  • ApolloMed IPO

    Co-founded ApolloMed (NASDAQ: AMEH), completed IPO in 2008, raised over $200 million in capital. Peak market cap of $1.4 billion during Warren’s tenure. Private placement investors generated 28x+ their investments

  • Bancorp IPO

    Co-founded The Bancorp, led the company through its IPO in 2000. Under Frank’s leadership, from 1999 to 2006, the stock price surged from $9.50 to $28.50, a return of 200%+

  • Above Average IRR

    50+% IRR Delivered on 17+ billion across 20+ public exits

ApolloMed IPO

Co-founded ApolloMed (NASDAQ: AMEH), completed IPO in 2008, raised over $200 million in capital. Peak market cap of $1.4 billion during Warren’s tenure. Private placement investors generated 28x+ their
investments

Nothing on this website should be deemed to be investment advice. The views and forecasts expressed in any materials on this website are as of the date indicated, are subject to change without notice, may not come to pass and do not represent a recommendation or offer of any particular security, strategy, or investment. Maximus Value Capital Partners has no obligation to provide revised assessments in the event of changed circumstances. There can be no assurance that the strategies described will achieve their objectives and goals. All content is subject to our terms and conditions of use policy.

 

 

Businesses

Corporate Information

Copyright © 2022 Maximus Value Capital Partners      Privacy Statement      Terms of Use